2,3 difosfoglicerato nel neonato pretermine

Translated title of the contribution: 2,3 dyphosphoglycerate in the prêterai newborn

Fabio Scopesi, Cesare Arioni, Silvana Canini, Pasquale Lantieri, Massimo Mazzella, Giovanni Serra

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: It has been largely shown that during the first month of life, in the preterm neonate Hb levels and Hct percentages rapidly decrease, high HbF concentration persists and a high oxygen affinity occurs. Data are needed to establish the level at which 2,3 dyphosphoglycerate (2,3 DPG) interacts with the regulation of oxygen affinity. Subjects and methods: 24 samples, from eight uncomplicated preterm newborns (34.1 ± 1.83 GW, 1869 ± ±291 BW) obtained at the same time as those required for the clinical management of the infants, were collected on the 2 nd, 7 th and 14 th day of life. Blood gases, total hemoglobin and hematocrit were obtained from 0.3ml arterialised capillary blood. Assays of 2,3 DPG were made separately on 0,4 ml venous blood. Results: As expected tHb concentration and Hct percentages significantly decreased from day2 to day4 in all eight cases. On the contrary 2,3 DPG and p50 values remained stable. Subsequently throughout the study period all neonates had an increased 2,3DPG/Hb ratio that was significantly related with p50 at standard conditions (p <0.05). Conclusions: Stable 2,3 DPG concentrations during all study period have been detected. The subsequent significant increased 2.3DPG/Hb, ratio related to increased p50 values, could have a key role in a physiological mechanism aimed to ensure adequate oxygen delivery to the tissues and to counteract the higher oxygen affinity of fetal hemoglobin. A wider sample is needed to validate this hypothesis.

Original languageItalian
Pages (from-to)621-626
Number of pages6
JournalActa Biomedica
Volume71
Issue numberSUPPL. 1
Publication statusPublished - 2000

Fingerprint

Newborn Infant
Oxygen
Fetal Hemoglobin
Hematocrit
Hemoglobins
Gases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Scopesi, F., Arioni, C., Canini, S., Lantieri, P., Mazzella, M., & Serra, G. (2000). 2,3 difosfoglicerato nel neonato pretermine. Acta Biomedica, 71(SUPPL. 1), 621-626.

2,3 difosfoglicerato nel neonato pretermine. / Scopesi, Fabio; Arioni, Cesare; Canini, Silvana; Lantieri, Pasquale; Mazzella, Massimo; Serra, Giovanni.

In: Acta Biomedica, Vol. 71, No. SUPPL. 1, 2000, p. 621-626.

Research output: Contribution to journalArticle

Scopesi, F, Arioni, C, Canini, S, Lantieri, P, Mazzella, M & Serra, G 2000, '2,3 difosfoglicerato nel neonato pretermine', Acta Biomedica, vol. 71, no. SUPPL. 1, pp. 621-626.
Scopesi F, Arioni C, Canini S, Lantieri P, Mazzella M, Serra G. 2,3 difosfoglicerato nel neonato pretermine. Acta Biomedica. 2000;71(SUPPL. 1):621-626.
Scopesi, Fabio ; Arioni, Cesare ; Canini, Silvana ; Lantieri, Pasquale ; Mazzella, Massimo ; Serra, Giovanni. / 2,3 difosfoglicerato nel neonato pretermine. In: Acta Biomedica. 2000 ; Vol. 71, No. SUPPL. 1. pp. 621-626.
@article{526d42823fe24f3c991748f8c7faf46a,
title = "2,3 difosfoglicerato nel neonato pretermine",
abstract = "Background: It has been largely shown that during the first month of life, in the preterm neonate Hb levels and Hct percentages rapidly decrease, high HbF concentration persists and a high oxygen affinity occurs. Data are needed to establish the level at which 2,3 dyphosphoglycerate (2,3 DPG) interacts with the regulation of oxygen affinity. Subjects and methods: 24 samples, from eight uncomplicated preterm newborns (34.1 ± 1.83 GW, 1869 ± ±291 BW) obtained at the same time as those required for the clinical management of the infants, were collected on the 2 nd, 7 th and 14 th day of life. Blood gases, total hemoglobin and hematocrit were obtained from 0.3ml arterialised capillary blood. Assays of 2,3 DPG were made separately on 0,4 ml venous blood. Results: As expected tHb concentration and Hct percentages significantly decreased from day2 to day4 in all eight cases. On the contrary 2,3 DPG and p50 values remained stable. Subsequently throughout the study period all neonates had an increased 2,3DPG/Hb ratio that was significantly related with p50 at standard conditions (p <0.05). Conclusions: Stable 2,3 DPG concentrations during all study period have been detected. The subsequent significant increased 2.3DPG/Hb, ratio related to increased p50 values, could have a key role in a physiological mechanism aimed to ensure adequate oxygen delivery to the tissues and to counteract the higher oxygen affinity of fetal hemoglobin. A wider sample is needed to validate this hypothesis.",
author = "Fabio Scopesi and Cesare Arioni and Silvana Canini and Pasquale Lantieri and Massimo Mazzella and Giovanni Serra",
year = "2000",
language = "Italian",
volume = "71",
pages = "621--626",
journal = "Acta Biomedica de l'Ateneo Parmense",
issn = "0392-4203",
publisher = "L'Ateneo Parmense",
number = "SUPPL. 1",

}

TY - JOUR

T1 - 2,3 difosfoglicerato nel neonato pretermine

AU - Scopesi, Fabio

AU - Arioni, Cesare

AU - Canini, Silvana

AU - Lantieri, Pasquale

AU - Mazzella, Massimo

AU - Serra, Giovanni

PY - 2000

Y1 - 2000

N2 - Background: It has been largely shown that during the first month of life, in the preterm neonate Hb levels and Hct percentages rapidly decrease, high HbF concentration persists and a high oxygen affinity occurs. Data are needed to establish the level at which 2,3 dyphosphoglycerate (2,3 DPG) interacts with the regulation of oxygen affinity. Subjects and methods: 24 samples, from eight uncomplicated preterm newborns (34.1 ± 1.83 GW, 1869 ± ±291 BW) obtained at the same time as those required for the clinical management of the infants, were collected on the 2 nd, 7 th and 14 th day of life. Blood gases, total hemoglobin and hematocrit were obtained from 0.3ml arterialised capillary blood. Assays of 2,3 DPG were made separately on 0,4 ml venous blood. Results: As expected tHb concentration and Hct percentages significantly decreased from day2 to day4 in all eight cases. On the contrary 2,3 DPG and p50 values remained stable. Subsequently throughout the study period all neonates had an increased 2,3DPG/Hb ratio that was significantly related with p50 at standard conditions (p <0.05). Conclusions: Stable 2,3 DPG concentrations during all study period have been detected. The subsequent significant increased 2.3DPG/Hb, ratio related to increased p50 values, could have a key role in a physiological mechanism aimed to ensure adequate oxygen delivery to the tissues and to counteract the higher oxygen affinity of fetal hemoglobin. A wider sample is needed to validate this hypothesis.

AB - Background: It has been largely shown that during the first month of life, in the preterm neonate Hb levels and Hct percentages rapidly decrease, high HbF concentration persists and a high oxygen affinity occurs. Data are needed to establish the level at which 2,3 dyphosphoglycerate (2,3 DPG) interacts with the regulation of oxygen affinity. Subjects and methods: 24 samples, from eight uncomplicated preterm newborns (34.1 ± 1.83 GW, 1869 ± ±291 BW) obtained at the same time as those required for the clinical management of the infants, were collected on the 2 nd, 7 th and 14 th day of life. Blood gases, total hemoglobin and hematocrit were obtained from 0.3ml arterialised capillary blood. Assays of 2,3 DPG were made separately on 0,4 ml venous blood. Results: As expected tHb concentration and Hct percentages significantly decreased from day2 to day4 in all eight cases. On the contrary 2,3 DPG and p50 values remained stable. Subsequently throughout the study period all neonates had an increased 2,3DPG/Hb ratio that was significantly related with p50 at standard conditions (p <0.05). Conclusions: Stable 2,3 DPG concentrations during all study period have been detected. The subsequent significant increased 2.3DPG/Hb, ratio related to increased p50 values, could have a key role in a physiological mechanism aimed to ensure adequate oxygen delivery to the tissues and to counteract the higher oxygen affinity of fetal hemoglobin. A wider sample is needed to validate this hypothesis.

UR - http://www.scopus.com/inward/record.url?scp=0034577344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034577344&partnerID=8YFLogxK

M3 - Articolo

VL - 71

SP - 621

EP - 626

JO - Acta Biomedica de l'Ateneo Parmense

JF - Acta Biomedica de l'Ateneo Parmense

SN - 0392-4203

IS - SUPPL. 1

ER -